Fibromyalgia
Conditions
Interventions
This is a randomized blinded clinical trial based on the previous sample size calculation 75 participants will be required and will be divided into three groups GEAIA Aerobic exercise and active trans
E02.774
Sponsors
Departamento de Biociências -Baixada Santista
Universidade Federal de São Paulo - Campus Baixada Santista
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: This study will include individuals of female sex; aged between 18 and 60 years; with a diagnosis of FM that will be scheduled by a specialized physician selected by the patient and later confirmed by a physical therapist who holds a doctorate and has eight years of experience in the area of Rheumatology taking into account the FM diagnostic criteria of the American College of Rheumatology Widespread Pain Index WPI greater or equal to 7 and Symptom Severity Scale ESS greater or equal to 5 or WPI of 4 to 6 and ESS score greater or equal to 9 widespread pain defined as pain in at least 4 of the 5 regions jaw symptoms and abdominal pain are not included in the definition of widespread pain and symptoms present for at least 3 months with cognitive capacity to understand the study according to the cut-off score of the Mini-Mental State Examination classified as slightly active and irregularly active according to criteria established by the International Physical Activity Questionnaire administered in its short version have a medical certificate allowing physical activity and interest in participating in the entire experimental protocol
Exclusion criteria
Exclusion criteria: Presence of uncontrolled systemic diseases, such as diabetes mellitus and systemic arterial hypertension; Neurological and musculoskeletal conditions that may directly interfere with the evaluations, such as paralysis, significant changes in sensitivity, advanced joint diseases (such as arthroplasties or osteoarthritis); Individuals who are malnourished (BMI < 18.5 kg/m2) or morbidly obese (BMI = 40 kg/m2); Absolute contraindication for photobiomodulation, such as the presence of neoplasia; Failure to present a medical certificate to perform physical exercise will prevent participation in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in cardiorespiratory capacity through the variables: maximum oxygen consumption (VO2 max); and anaerobic threshold that will be analyzed through the cardiopulmonary ergometric test. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in the level of perceived fatigue assessed by the Fatigue Severity Scale (FSS) and performance fatigue measured by the Biodex Multi-Joint System 4 isokinetic dynamometer, improvement in the level of pain measured by the Visual Analog Scale, less impact of FM on quality of life assessed by the Revised Fibromyalgia Impact Questionnaire (FIQR) and improvement in functional capacity assessed by the 6-Minute Walk Test (6MWT) | — |
Countries
Brazil
Contacts
Public ContactThatiane Santos
Universidade Federal de São Paulo - Campus Baixada Santista
Outcome results
None listed